Product
CKD-386
1 clinical trial
1 indication
Indication
Hypertension and DyslipidemiaClinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-386 With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-11-27